Research And Development

The Rouse Co., which founded Columbia as a community of diversity and tolerance, has decided to name its newest neighborhood after a U.S. senator who fought to keep his political power by depriving blacks of the right to vote. The company's development arm wants to call the 517-acre project north of Laurel Gorman's Promise after U.S. Sen. Arthur Pue Gorman, a Howard County native who was an early baseball player and the state's Democratic Party boss for 30 years. But yesterday, David E. Forester, vice president for Howard Research and Development, said the company will investigate the revelations about Gorman's efforts to disenfranchise blacks.

The Rouse Co., which founded Columbia as a community of diversity and tolerance, has decided to name its newest neighborhood after a U.S. senator who fought to keep his political power by depriving blacks of the right to vote. The company's development arm wants to call the 517-acre project north of Laurel Gorman's Promise after U.S. Sen. Arthur Pue Gorman, a Howard County native who was an early baseball player and the state's Democratic Party boss for 30 years. But yesterday, David E. Forester, vice president for Howard Research and Development, said the company will investigate the revelations about Gorman's efforts to disenfranchise blacks.

WASHINGTON -- When the U.S. military impressed the world in the 1991 Persian Gulf war by making cruise missiles turn street corners to hit targeted Baghdad buildings, it was exploiting "smart weapons" technology developed a decade earlier.That 10-year lag between developing a weapon and using it is at the core of growing bipartisan concern that today's cash-strapped Pentagon is jeopardizing U.S. weapons superiority in the 21st century.The central fear, voiced during a Senate Armed Services Committee hearing yesterday, is that research and development on the next generation of weaponry is being deferred by the Clinton administration to pay for day-to-day military operations.

Hunter Manufacturing Co., a leader in the design and manufacture of security systems for military and homeland defense applications, has announced plans for a facility in Edgewood. The Applied Research Center will be a 6,800-square-foot site in Emmorton Business Park. The center will develop chemical and biological defense products and will provide consulting services. The facility will also be equipped with state-of-the-art laboratory and testing facilities and will provide product modeling and prototyping capabilities for filtration materials.

Baltimore Biotechnology Inc., a tiny research and development company headed by a well-known retinal surgeon at St. Joseph Hospital, has been acquired by a California company in exchange for roughly $700,000 in stock based on current prices.With the purchase, Celtrix Pharmaceuticals Inc., of Santa Clara, will be tapping into the work of the six Baltimore Biotech researchers who have developed new technology that uses biotechnology to treat eye diseases.Celtrix will also have a closer relationship with Dr. Bert M. Glaser, founder of Baltimore Biotech and director of the Retina Center at St. Joseph.

A new study by a University of Maryland researcher says research and development spending at universities has a positive impact on creating high-wage high-technology jobs, but that later-stage research leading directly to new products does much more to create jobs.The study, written by Zoltan Acs of the College Park campus' Center for International Business Education and Research and two Scottish academics, traced R&D spending and high-tech job growth in 37 U.S. cities. The authors concluded that doubling university research and development spending on average increases high-tech employment by 8 percent.

China's manufacturing cost advantage, growing research and development efforts and millions of science and engineering graduates are helping Beijing rapidly catch up with the United States' high-tech capabilities - posing not just an educational and economic challenge but also a potential military threat. Let's connect some of the dots: Almost half the states are doing a poor job setting high enough academic standards for science in their public schools, according to a report recently released by the Thomas B. Fordham Institute.

The first building on the 400-acre research and development complex under development at Aberdeen Proving Ground has opened and is fully leased. Rockville-based Opus East, which is developing the Government and Technology Enterprise, or GATE, site in partnership with the Army, designed the $12 million structure to suit the needs of CACI International Inc., a technical consultant and federal contractor headquartered in Arlington, Va. The 60,000-square-foot structure...

Human Genome Sciences Inc. said yesterday that its first-quarter loss narrowed despite increased operating expenses and flat revenue, thanks to one-time expenses that inflated its loss a year ago. The Rockville-based developer of gene-based drugs reported a quarterly loss of $13 million, or 10 cents a share, compared with a loss of $72.5 million, or 70 cents a share, in the first quarter last year. Revenue was $5.3 million, even with the 2000 quarter. Revenue from a year ago was restated to comply with a change in accounting rules.

EntreMed Inc. reported yesterday that its fourth-quarter loss narrowed as research and development costs fell while revenue rose. EntreMed reported a fourth-quarter loss of $13.7 million, or 82 cents a share, compared with $14.8 million, or $1.01 a share, in the year-ago period. Revenue was $1.2 million, up from $458,163, thanks to royalties from increased sales of Thalomid, a drug EntreMed licensed to Celgene Corp. Analysts surveyed by Nelson's had expected a loss of 85 cents a share.